Michalis Mastri

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Emergency Department

Tyrosine Kinase

Chronic Myeloid Leukemia

Immune Response

Top Venues

Molecular cancer therapeutics

Molecular & cellular oncology

PLoS computational biology

This page only lists publications with an associated author ORCID identifier.

Publications

Melissa Dolan, Yuhao Shi, Michalis Mastri, Mark D Long, Amber McKenery, James W Hill, Cristina Vaghi, Sebastien Benzekry, Joseph J Barbi, John M L Ebos
A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling. Molecular cancer therapeutics (2024)
Melissa Dolan, Yuhao Shi, Michalis Mastri, Mark D Long, Amber McKenery, James W Hill, Cristina Vaghi, Sebastien Benzekry, Joseph J Barbi, John M L Ebos
A senescence-mimicking (senomimetic) VEGFR TKI side-effect primes tumor immune responses via IFN/STING signaling. Molecular cancer therapeutics (2024)
Cristina Vaghi, Anne Rodallec, Raphaëlle Fanciullino, Joseph Ciccolini, Jonathan P Mochel, Michalis Mastri, Clair Poignard, John M L Ebos, Sebastien Benzekry
Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors. PLoS computational biology 16 (2) (2020)
Michalis Mastri, John M L Ebos
Tumor growth fueled by spurious senescence phenotypes. Molecular & cellular oncology 6 (2) (2019)